Neutral impactCompany

Eveready Industries India Limited — Analysts/Institutional Investor Meet/Con. Call Updates

NSE 2 hrs ago·23 Oct 2026, 11:17 am
Eveready Inds. IND

Eveready Industries India Limited has informed the Exchange about Schedule of meet

Affected stocks

Neutral1 stock

Eveready Inds. IND

EVEREADY Neutral

₹314.45

Bull / bear label is derived from the article's AI sentiment — indicative, not advice. Prices may be delayed.

Key takeaways

  • Concerns Eveready Inds. IND (EVEREADY).
  • Category: Company.

Why it matters

A routine update for Eveready Inds. IND. Use the price and stock snapshot to gauge how the market is responding.

Summary & analysis by DocStoX. Full story at NSE.

More Company news

More news
OIL AND Natural GAS Corp.

Oil & Natural Gas Corporation Limited — Board Meeting Intimation

OIL AND Natural GAS Corp.₹225.00▼ 1.10%

NSE · 31 min ago

Asset Reconstruc CO (I) L

Asset Reconstruction Company (India) Limited — Board Meeting Intimation

Asset Reconstruc CO (I) L₹124.38▲ 5.25%

NSE · 32 min ago

Dixon Techno (india)

Dixon Technologies (India) Limited — Board Meeting Intimation

Dixon Techno (india)₹11,594.00▲ 3.60%

NSE · 32 min ago

Vivid Electromech

Vivid Electromech Limited — Outcome of Board Meeting

Vivid Electromech₹1,343.30▲ 6.28%

NSE · 33 min ago

Shakti Pumps (I)

Shakti Pumps (India) Limited — Outcome of Board Meeting

Shakti Pumps (I)₹400.65▲ 3.63%

NSE · 34 min ago

Indo Rama Synthetics

Indo Rama Synthetics (India) Limited — Investor Presentation

Indo Rama Synthetics₹76.97▲ 3.33%

NSE · 35 min ago

MAX Healthcare INS

Max Healthcare Institute Limited — Analysts/Institutional Investor Meet/Con. Call Updates

MAX Healthcare INS₹817.00▲ 0.25%

NSE · 35 min ago

Gujarat Kidney N SUP SP L

Gujarat Kidney And Super Speciality Limited — Board Meeting Intimation

Gujarat Kidney N SUP SP L₹179.46▲ 1.71%

NSE · 35 min ago

Kilitch Drugs India

Kilitch Drugs (India) Limited — Change in Directors/KMP/SMP/Auditor/RTA

Kilitch Drugs India₹202.11▼ 0.06%

NSE · 36 min ago

Aggregated from third-party sources for research. Sentiment & impact are AI-generated, indicative, not advice.